JP2013500940A5 - - Google Patents

Download PDF

Info

Publication number
JP2013500940A5
JP2013500940A5 JP2012505915A JP2012505915A JP2013500940A5 JP 2013500940 A5 JP2013500940 A5 JP 2013500940A5 JP 2012505915 A JP2012505915 A JP 2012505915A JP 2012505915 A JP2012505915 A JP 2012505915A JP 2013500940 A5 JP2013500940 A5 JP 2013500940A5
Authority
JP
Japan
Prior art keywords
antibody
subject
sample
alzheimer
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012505915A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013500940A (ja
JP5599454B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2010/004926 external-priority patent/WO2011016239A1/fr
Publication of JP2013500940A publication Critical patent/JP2013500940A/ja
Publication of JP2013500940A5 publication Critical patent/JP2013500940A5/ja
Application granted granted Critical
Publication of JP5599454B2 publication Critical patent/JP5599454B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012505915A 2009-08-06 2010-08-05 Ａβオリゴマーに特異的に結合する抗体およびその利用 Expired - Fee Related JP5599454B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23179709P 2009-08-06 2009-08-06
US61/231,797 2009-08-06
US28255010P 2010-02-26 2010-02-26
US61/282,550 2010-02-26
PCT/JP2010/004926 WO2011016239A1 (fr) 2009-08-06 2010-08-05 Anticorps qui se lient spécifiquement à des oligomères bêta a et utilisation de ceux-ci

Publications (3)

Publication Number Publication Date
JP2013500940A JP2013500940A (ja) 2013-01-10
JP2013500940A5 true JP2013500940A5 (fr) 2014-05-15
JP5599454B2 JP5599454B2 (ja) 2014-10-01

Family

ID=43544148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012505915A Expired - Fee Related JP5599454B2 (ja) 2009-08-06 2010-08-05 Ａβオリゴマーに特異的に結合する抗体およびその利用

Country Status (7)

Country Link
US (1) US8613924B2 (fr)
EP (1) EP2462162B1 (fr)
JP (1) JP5599454B2 (fr)
CN (1) CN102596997B (fr)
DK (1) DK2462162T3 (fr)
ES (1) ES2614949T3 (fr)
WO (1) WO2011016239A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE033325T2 (en) * 2007-01-05 2017-11-28 Univ Zuerich Anti-beta-amyloid binder antibodies and their use
IL199534A (en) 2007-01-05 2013-01-31 Univ Zuerich An isolated human antibody capable of detecting a neoepitope in a disease-related protein, a polynucleotide encoding an antibody, a vector containing the polynucleotide, a host cell containing the polynucleotide or vector, a preparation containing the antibody and related methods and uses.
AU2008312802A1 (en) * 2007-10-19 2009-04-23 Immunas Pharma, Inc. Antibody capable of specifically binding to abeta oligomer, and use thereof
PT2246427T (pt) 2008-02-08 2017-03-03 Immunas Pharma Inc Anticorpos capazes de se ligar especificamente a oligómeros beta amilóides e a sua utilização
EP2321348A2 (fr) * 2008-07-09 2011-05-18 University of Zürich Procédé d'activation de la neurogenèse
US9085614B2 (en) 2008-08-01 2015-07-21 Immunas Pharma, Inc. Antibodies that specifically bind to Aβ oligomers and uses thereof
CN102317316B (zh) 2008-12-19 2014-08-13 帕尼玛制药股份公司 人抗α突触核蛋白自身抗体
ES2641612T3 (es) 2009-04-17 2017-11-10 Immunas Pharma, Inc. Anticuerpos que se unen específicamente a oligómeros de beta A y uso de los mismos
CN102574915B (zh) 2009-08-06 2014-10-22 伊缪纳斯制药株式会社 特异性结合Aβ寡聚体的抗体及其用途
US9320793B2 (en) * 2010-07-14 2016-04-26 Acumen Pharmaceuticals, Inc. Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42
BR112013033258B1 (pt) 2011-06-23 2022-09-20 University Of Zurich Anticorpo isolado ou fragmento de ligação ao antígeno do mesmo que se liga a alfasinucleína, composição e seus usos
US9588129B2 (en) * 2013-03-15 2017-03-07 Amira Medical Technologies Inc. Methods for analyzing blood to detect diseases associated with abnormal protein aggregation
CN107074938A (zh) * 2014-10-16 2017-08-18 豪夫迈·罗氏有限公司 抗‑α‑突触核蛋白抗体和使用方法
MA41115A (fr) 2014-12-02 2017-10-10 Biogen Int Neuroscience Gmbh Procédé de traitement de la maladie d'alzheimer
IL272773B2 (en) 2017-08-22 2024-06-01 Biogen Ma Inc Pharmaceutical preparations containing anti-amyloid cell antibodies
CN108020673A (zh) * 2017-11-15 2018-05-11 首都医科大学宣武医院 Aβ试剂盒、检测方法及应用
EP3762031A4 (fr) * 2018-03-08 2021-12-22 Phanes Therapeutics, Inc. Anticorps anti-claudine 18.2 et leurs utilisations
SG11202008098TA (en) * 2018-03-28 2020-10-29 Axon Neuroscience Se Antibody-based methods of detecting and treating alzheimer's disease
CN117024587A (zh) * 2019-03-07 2023-11-10 瑞阳(苏州)生物科技有限公司 人IL-1β蛋白结合分子及其编码基因和应用
US20230034474A1 (en) * 2019-09-10 2023-02-02 Ac Immune Sa Novel Molecules for Diagnosis
CN114573694B (zh) * 2020-12-01 2023-09-01 深圳华柏生物科技有限公司 一种抗IL13Rα2抗体及其制备方法和用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239102A3 (fr) 1986-03-28 1989-07-12 Tsuji, Kimiyoshi Procédé de préparation d'un hybridome humain-humain
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
ES2301158T3 (es) 1992-07-24 2008-06-16 Amgen Fremont Inc. Produccion de anticuerpos xenogenicos.
JPH08509612A (ja) 1993-04-26 1996-10-15 ジェンファーム インターナショナル インコーポレイテッド 異種抗体を産生することができるトランスジェニック非ヒト動物
DE69637481T2 (de) 1995-04-27 2009-04-09 Amgen Fremont Inc. Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
AU2466895A (en) 1995-04-28 1996-11-18 Abgenix, Inc. Human antibodies derived from immunized xenomice
US20030068316A1 (en) * 1997-02-05 2003-04-10 Klein William L. Anti-ADDL antibodies and uses thereof
US6218506B1 (en) 1997-02-05 2001-04-17 Northwestern University Amyloid β protein (globular assembly and uses thereof)
AR022952A1 (es) 1999-03-19 2002-09-04 Smithkline Beecham Corp ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
AUPR617901A0 (en) 2001-07-06 2001-08-02 Pacmab Pty Ltd Method for treating multiple myeloma
DE60226036T9 (de) 2001-08-03 2016-09-29 Medical & Biological Laboratories Co., Ltd. ANTIKÖRPER, DER DAS GM1-GANGLIOSID-GEBUNDENE AMYLOID-b-PROTEIN ERKENNT, UND DNA, DIE FÜR DIESEN ANTIKÖRPER CODIERT
WO2010012004A2 (fr) 2008-07-25 2010-01-28 The Regents Of The University Of California Anticorps monoclonaux spécifiques d'agrégats amyloïdes pathologiques communs aux amyloïdes formés à partir de protéines ayant des séquences différentes
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
US8394379B2 (en) 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
AU2005269940A1 (en) * 2004-07-02 2006-02-09 Northwestern University Monolocal antibodies that target pathological assemblies of amyloid beta (Abeta)
US20080044356A1 (en) 2004-10-22 2008-02-21 Regents Of The University Of Minnesota Assemblies of Oligomeric Amyloid Beta Protein and Uses Thereof
AU2005306997B2 (en) 2004-10-25 2012-07-05 Merck Sharp & Dohme Corp. Anti-ADDL antibodies and uses thereof
US8029794B2 (en) * 2004-12-10 2011-10-04 Novimmune S.A. Combining therapies targeting multiple toll-like receptors
WO2006066171A1 (fr) 2004-12-15 2006-06-22 Neuralab Limited Anticorps amyloide ???? utilises afin d'ameliorer la cognition
EP1853299A4 (fr) 2005-01-14 2009-11-11 Univ California Compositions et methodes d'inhibition de la formation de drusen et methodes de diagnostic ou de traitement de pathologies liees aux drusen
AU2006222193B2 (en) 2005-03-05 2011-11-17 AbbVie Deutschland GmbH & Co. KG Screening method, process for purifying of non-diffusible A-beta oligomers, selective antibodies against said non-diffusible A-beta oligomers and a process for manufacturing of said antibodies
EP1921137A4 (fr) 2005-06-21 2011-01-26 Med & Biological Lab Co Ltd Anticorps avec effet inhibiteur sur la formation de fibrilles amyloïdes
EP1749839A1 (fr) 2005-07-22 2007-02-07 Novoplant GmbH Polypeptides de liaison d'antigènes F4 (K88) fimbriae
RU2429244C2 (ru) * 2006-03-23 2011-09-20 Байоарктик Ньюросайенс Аб Улучшенные селективные в отношении протофибрилл антитела и их применение
US20090232801A1 (en) 2007-05-30 2009-09-17 Abbot Laboratories Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof
AU2008312802A1 (en) 2007-10-19 2009-04-23 Immunas Pharma, Inc. Antibody capable of specifically binding to abeta oligomer, and use thereof
US20100291071A1 (en) 2008-08-01 2010-11-18 Immunas Pharma, Inc. Antibody Specific Binding to A-Beta Oligomer and the Use
PT2246427T (pt) 2008-02-08 2017-03-03 Immunas Pharma Inc Anticorpos capazes de se ligar especificamente a oligómeros beta amilóides e a sua utilização
US9085614B2 (en) 2008-08-01 2015-07-21 Immunas Pharma, Inc. Antibodies that specifically bind to Aβ oligomers and uses thereof
ES2641612T3 (es) 2009-04-17 2017-11-10 Immunas Pharma, Inc. Anticuerpos que se unen específicamente a oligómeros de beta A y uso de los mismos
CN102574915B (zh) 2009-08-06 2014-10-22 伊缪纳斯制药株式会社 特异性结合Aβ寡聚体的抗体及其用途

Similar Documents

Publication Publication Date Title
JP2013500940A5 (fr)
JP2013500941A5 (fr)
KR101981351B1 (ko) 타우를 인식하는 포스포특이적 항체
RU2743152C2 (ru) Гуманизированные анти-тау-антитела
KR101988672B1 (ko) 타우를 인식하는 포스포특이적 항체
JP2015530971A5 (fr)
DK2732289T3 (en) ANTIBODIES, KIT AND IN VITRO METHOD FOR DETECTING BETA AMYLOID OLIGOMERS
JP7399096B2 (ja) 神経変性を検出するためのアッセイ
FI2897981T3 (fi) Anti-CD3-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat CD3:a ja CD20:ta, ja niiden käyttöjä
JP2015531768A5 (fr)
AU2016353553B2 (en) Amyloid beta epitopes and antibodies thereto
JP2016511254A5 (fr)
JP7109467B2 (ja) タウに特異的に結合する結合分子
JP2014530597A5 (fr)
RU2016141561A (ru) Связывающие элементы к фно-альфа
JP2014533357A5 (fr)
JP2016503293A5 (fr)
JP2015527365A5 (fr)
CN113891746A (zh) 焦谷氨酸淀粉样蛋白-β的抗体及其用途
JP2018525320A5 (fr)
JP2021513077A (ja) 認知症の診断および／または予測のためのアドレノメデュリン（ａｄｍ）、ならびに認知症の治療または予防における使用のための抗アドレノメデュリンバインダー
WO2012021475A2 (fr) ANTICORPS CONTRE LE PEPTIDE N3pGLU AMYLOÏDE BÊTA ET LEURS UTILISATIONS
JP2015522562A5 (fr)
WO2011045945A1 (fr) ANTICORPS RECONNAISSANT UNE STRUCTURE EN SPIRE D'AMYLOÏDE β
US9176151B2 (en) Antibodies, kit and method for detecting amyloid beta oligomers